» Symposium Program

Session 2: Recent Advances in Liquid Chromatography

Melissa Hanna-Brown
Pfizer, UK
“The Impact of peaks and troughs in separation science: Innovation to pharmaceutical development”

Thiruvengadam Parthasarathy
Performics Biolabs Pvt Ltd, India
“Fast liquid chromatography: A challenging need in pharmaceutical analysis”

David Llyod
Bristol Myers Squibb, USA
"Speeding up pharmaceutical analyses"

Session 3: Instrument Analysis in Drug Discovery Analysis
Carlo Bertucci

University of Bologna, Italy
“Circular dichroism in the monitoring of protein-protein interactions: the value for drug discovery”

Roman Kaliszan
Gdansk Medical University, Poland
"Association constants of a series of pyridine and piperidine alkaloids with amyloid beta-peptide as determined by electrochemical spectroscopy"

Session 4: Recent Advances in Sample Preparation

Jun Haginaka
Mukogawa Women's University, Japan
"Molecularly imprinted polymers as affinity extraction media"

Klaus-Siegfried Boos
University of Munich, Germany
"Processing of whole blood samples for LC-MS analysis of small molecules: An update"

Januz Pawlizyn
University of Waterloo, Canada
"High throughput SPME techniques for pharmaceutical determinations"

Session 5: Recent Advances in Chiral Analysis I

Daniel Armstrong
University of Texas, USA
"New frontiers in enantiomeric separations"

Wolfgang Lindner
University of Vienna, Austria
"The potential of chiral ion exchangers for stereoselective analysis"

Ch. Lakshmi Narayana
Diachel Chiral Technologies (India) Pvt.
“Enantiomeric separation of proton pump inhibitors using liquid chromatography and super critical fluid chromatography”

Session 6: DMPK and clinical studies

Subrahmanyam Vangala
Sai Advantium Pharma Ltd, India

Prateek Bhatia
National Institute on Aging/NIH, USA
“Online identification of ABC transporter substrates”

Irving W. Wainer
National Institute on Aging/NIH, USA
“The effect of age and clinical status on pharmacokinetics and drug metabolism: Explaining unexpected observations and finding new therapeutic approaches”

Session 7: Process Analysis and Quality Control

Koduru Surendranath
United States Pharmacopeia, India
“Good Practices in Pharmaceutical Analysis"

P.S. Ramanathan
Gharda Chemicals Ltd., India
“The importance of measurement uncertainty in reporting analytical results”

H. Thomas Karnes
Virginia Commonwealth University School of Pharmacy, USA
“A fixed range decision criteria approach for method transfer and other data comparisons”

Christopher M. Riley
Riley and Rabel Consulting Services, LLC, USA
“Critical issues in the control of impurities in drug substance and drug product, with emphasis on the analytical guidelines”

Session 8:Panel Discussion: Meeting ICH and FDA Guidelines

Koduru Surendranath
United States Pharmacopeia, India

P.S. Ramanathan
Gharda Chemicals Ltd., India

H. Thomas Karnes
Virginia Commonwealth University School of Pharmacy, USA

Christopher M. Riley
Riley and Rabel Consulting Services, LLC, USA

Session 9: Recent Advances in Chiral Analysis II

Jacques Crommen
Universite De Liege, Belgium
"New developments in enantioseparations by non-aqueous capillary electrophoresis using charged cyclodextrins as charged selectors"

Valliappan Kannappan
Annamalai Univeristy, India
"Enantioselective release of drug enantiomers from chiral formulations: Interaction of chiral drugs with chiral excipients"

Jelena Kocergin
Regis technologies, USA
“Regis Technologies approach to chiral analytical and preparative separations”

Session 10: The Identification of Biomarkers and New Drug Candidates”

John Stobaugh
University of Kansas, USA
"Enabling chemistries for the detection and relative quantitation of oxidative stress biomarkers: Stable isotope labeling of protein 3-nitrotyrosine and protein 3-hydroxytyrosine”

Ruin Moaddel
National Institute on Aging/NIH, NIH, USA
"Ligand fishing with immobilized protein-magnetic beads"

Session 11: The Application of Mass Spectrometry to Pharmaceutical and Biomedical Analysis

Paul Ho
National University of Singapore, Singapore
"Identification of stereoisomeric metabolites of meisoindigo by achiral and chiral LC-MS/MS"

Yasser Ismail
Waters Corporation, USA

Session 12: Identification and Characterization of Natural Products

K.V. Pugalendi
Annamalai University, India
“Antihyperlipidemic efficacy of flavonoid-rich fraction of Spermacoce hispida seeds in hyperlipidemic and diabetic-hyperlipidemic rats and identification of compounds by reverse phase HPLC”

Quezia Cass
Universidade Federal de Sao Carlos, Brazil
"Quantification of a chemical marker versus chromatographic profile associated with Chemometrics for classification of herbal medicine"

Harish C. Joshi
Emory University, USA
“Herbs and Microtubules in Human Health and Disease: From Nature-to-Bench-to-Clinic”

Session 13: Studies of Biomolecular Interactions

Krzysztof Jozwiak
University of Lublin, Poland
"Computer modeling of the binding of fenoterol derivatives to beta-adrenergic receptors"

Toshihiko Hanai
Health Research Foundation, Institute Pasteur, Japan
"Quantitative analysis of enzyme reaction mechanisms for drug discovery and designing immunoassay"

Gregory W. Faris
SRI International, USA
“Nanodroplet microfluidics for bioanalysis”

Session14: The Identification and Characterization of New Drugs

Vincenza Andriasano
University of Bologna, Italy
"Alzheimer's disease drug discovery: New analytical approaches for lead selection and optimization"

Gabriella Massolini
University of Pavia, Italy
Screening of drug candidates for G-protein-coupled receptors using frontal affinity chromatography coupled to mass spectrometry

Boguslaw Buszewski
Nicolas Copernicus University, Poland
“Packing of supramolecular interactions for determination of compounds with biological activity”

Nurulain Zaveri
Molecule Medicine Research Institute, USA

Session 15: Automating Pharmaceutical and Biomedical Laboratories

Venkat Manohar
Nicholas Piramal (India) Ltd, India
“Automation in GLP Bioanalysis – Concerns and Care”

Sandra Furlanetto
University of Florence, Italy
"Optimization of capillary electrophoretic methods by multivariate approaches"

Session 16: Panel Discussion: Finding new medicines in the Indian biotica

Plenary lecture:
Panel:
K.V. Pugalendi
Annamalai University, India

Session 17: Pharmacokinetics for the chemist

John Stobaugh
University of Kansas, USA

Session 18: "Omics" in Pharmaceutical Studies

Rob Plumb
Waters Corporation, USA
"HPLC-MS-based metabonomics in the discovery and development of pharmaceuticals"

Guowang Xu
Dalian Institute of Chemical Physics the Chinese Academy of Sciences, Dalian, China
"LC-MS based metabonomics and its applications in clinical and pharmaceutical research"

Günther K. Bonn
University of Innsbruck, Austria
“New stationary phases for sample pretreatment and separation technologies in the ‘-omics’ area – Important tools for pharmaceutical studies”

Michal J. Markuszewski
Gdansk Medical University, Poland
"Application of metabonomic approach to study nucleosides profiles determined in urine of urogenital cancer patients"

Session 19: Pharmaceutical and Biomedical Sciences in India: Present Status and Future Prospects

S. Ravisankar
GVK Bio, India
“Regulatory Bioanalysis – Prospectives & Challenges”

Y.S. Lakshmi Narasimham
Nycomed Pharam Pvt Ltd, India
“Modern analytical techniques in drug discovery”

Prakash V. Diwan
National Institute of Pharmaceutical Education and research at Hyderabad, India

» Short Courses